In his inaugural address, President Joe Biden made it clear that confronting COVID-19 is a priority—and two days in, he's already taken action in the United States and globally. Here’s where things stand.
To ensure a coordinated COVID-19 response across the federal government, the Biden administration has named and placed acting agency leadership, including at Health and Human Services (HHS) and the President’s COVID-19 Advisory Board.
Meanwhile, Biden’s $1.9 trillion relief plan is awaiting congressional approval. The American Rescue Plan would boost federal unemployment assistance, create a new grant for small business owners, increase assistance to states and schools, and send $1,400 stimulus checks to most Americans. It would also invest $20 billion in a national COVID-19 vaccination program and $50 billion to increase COVID-19 testing.
(Want to know more about what to expect in the first 100 days?We just published a Biden administration preview.)
In addition, the Biden administration joined global efforts to fight the global pandemic,announcing that the United States will:
- Remain a member of the World Health Organization (WHO), and
- Participate in the Access to COVID-19 Tools (ACT) Accelerator and the COVID-19 Vaccine Global Access (COVAX) Facility, which aim to deliver COVID-19 vaccines to poor and under-developed countries.
What they’re saying: “This is a good day for WHO and a good day for global health,” said WHO Director-General Tedros Adhanom Ghebreyesus. “Since WHO’s founding in 1948, the United States has played a vital role in global health, and the American people have made enormous contributions to the health of the world’s people.”
Dr. Michelle’s Diagnosis: Medical breakthroughs in COVID can only fulfill their potential, and the global pandemic can only be effectively addressed if patients around the world get access to them. As the country developing more COVID vaccines and therapeutics than any other, it is appropriate and necessary that the United States also play a leadership role working with other countries and international organizations to make sure patients around the world receive them. BIO looks forward to working with the U.S. and other governments to achieve this critical goal. – BIO President and CEO Dr. Michelle McMurry-Heath
Read more on what to expect during the Biden administration’s first 100 days.
More Health Care News:
Bloomberg: Eli Lilly antibody cuts COVID-19 risk up to 80% in nursing home study
“The infused treatment, cleared for use in high-risk COVID patients with mild-to-moderate disease who haven’t been hospitalized, also significantly reduced the risk of symptomatic disease in nursing home workers, according to a statement from Lilly on Thursday.”